LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.

about

P2860

LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.

Item

http://www.wikidata.org/entity/Q48181263

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.

@en

LSD1

@nl

type

Item

label

LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.

@en

LSD1

@nl

prefLabel

LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.

@en

LSD1

@nl

P1433

Q48181263-73D87726-80AA-47DA-A444-BE89E73E118B

P1476

Q48181263-D532C863-ADCE-4E04-973F-B683A0DC7A87

P2093

Q48181263-250A6122-AF47-4BC9-A7FC-6675F2216D35

Q48181263-455BF55C-C70A-49A8-8B34-F13913F9141A

Q48181263-483BDBE0-04CF-4BE8-8209-339BD4198C58

Q48181263-4BBE2905-0401-4FEC-A786-A6B00FD1E487

Q48181263-B5BC67F9-E450-445E-8CB3-04F4495BBF69

Q48181263-C2215032-9EBE-42A9-829C-860AAEB1E750

P2860

Q48181263-05AF3ADF-B26D-4F05-B772-2B971B88900B

Q48181263-5CF9FF01-2BE1-49F1-93DD-6CA164FE54A3

Q48181263-6AF340A0-1AA0-4FF5-A3B0-B1D4B4C7633B

Q48181263-A84DA7F9-2530-497D-901A-C1385DA95FF9

Q48181263-A963D0A7-0CC3-41BC-88AE-E1E750EE5180

Q48181263-C714DEBB-3926-4A27-B570-001AEBF76A53

Q48181263-DB573BA5-3D82-4CE7-A594-B5EF78852063

Q48181263-E491CCF4-7394-4205-9E5E-23FC05D84E51

P31

Q48181263-F8F9967E-FDE0-43F3-BAF0-1871F583F246

P356

Q48181263-54AC6791-E83E-4E30-8B9C-D2E923B452FC

P407

Q48181263-81B4275E-7B15-4A09-A4D3-565C3206AB50

P4510

Q48181263-E3EB9409-F35B-40F9-B951-C538B729C38F

P50

Q48181263-89E6ACC9-20FB-4BAB-AB63-66C97B0FC1E5

P577

Q48181263-F35B2DB2-0CFD-43AF-9A2D-7A28D76B7049

P698

Q48181263-BD7B0857-91ED-4104-A2DB-892FCEB04105

P921

Q48181263-C9788AC5-F09F-41B8-8ECA-8B3F0CDCD321

P356

BJH.14983

P1433

British Journal of Haematology

P1476

LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.

@en

P2093

Christian Marx

http://www.w3.org/2001/XMLSchema#string

Franziska Ebert

http://www.w3.org/2001/XMLSchema#string

James F Beck

http://www.w3.org/2001/XMLSchema#string

Marie-Luise Lauterjung

http://www.w3.org/2001/XMLSchema#string

Miriam Zimmermann

http://www.w3.org/2001/XMLSchema#string

Sabine Becker

http://www.w3.org/2001/XMLSchema#string

P2860

Recent advances in targeted therapy for Ewing sarcoma

High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.

Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.

Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date.

Advances in the development of histone lysine demethylase inhibitors.

Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.

RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.

P31

scholarly article

P356

10.1111/BJH.14983

http://www.w3.org/2001/XMLSchema#string

P407

English

P4510

HAP1 KDM1A(-) 1

P50

Jürgen Sonnemann

P577

2017-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205263

http://www.w3.org/2001/XMLSchema#string

P921

cell line